Leidos Holdings, Inc. (LDOS) Q3 2024 Earnings Call Transcript Summary
Leidos Holdings, Inc. (LDOS) Q3 2024 Earnings Call Transcript Summary
Non-GAAP diluted EPS grew by 44%, showcasing robust earnings growth and substantial free cash flow conversion of 159%.The following is a summary of the Leidos Holdings, Inc. (LDOS) Q3 2024 Earnings Call Transcript:
以下是leidos控股公司（LDOS）2024年第三季度業績會交流摘要：
Financial Performance:
金融業績：
Leidos Holdings reported strong financial performance in Q3 2024, with revenues of $4.19 billion, up 7% year-over-year.
Adjusted EBITDA margin reached a new high of 14.2%, with adjusted EBITDA amounting to $596 million, a 32% increase year-over-year.
Non-GAAP diluted EPS grew by 44%, showcasing robust earnings growth and substantial free cash flow conversion of 159%.
The company completed $200 million worth of share repurchases and increased its quarterly dividend to $0.40 per share, a 5.3% increase.
Leidos控股公司報告2024年第三季度強勁的財務業績，營收爲41.9億美元，同比增長7%。
調整後的EBITDA利潤率達到新高的14.2%，調整後的EBITDA金額爲59600萬美元，同比增長32%。
非GAAP攤薄後每股收益增長44%，展示了強勁的盈利增長和159%的大幅自由現金流轉化。
公司完成了20000萬美元的股票回購，並將季度股息提高至每股0.40美元，同比增長5.3%。
Business Progress:
業務進展：
Leidos successfully executed its business strategies with a focus on Health & Civil segment expansion and differentiated managed health services.
The company has been actively engaging in share repurchase activities, clearing $450 million of its planned $500 million for the year.
The introduction of the North Star growth strategy and ongoing investments in technological enhancements like AI and virtual health solutions are driving future growth prospects.
Leidos成功執行了其業務策略，專注於健康與民事業務領域的拓展和差異化的管理醫療服務。
公司一直積極參與股份回購活動，已經完成了年度計劃的45000萬美元中的50000萬美元。
推出了北極星增長策略，持續投資於人工智能、虛擬健康解決方案等技術增強，推動未來增長前景。
Opportunities:
機會：
Continued strong demand in managed health services, particularly with disability and occupational health evaluations, driving sustained business performance.
Leidos is leveraging technological advancements, including AI, to enhance service capability and efficiency, positioning the company to benefit from future demands.
Expansion opportunities in the Health & Civil segment through the VA and various government and commercial projects.
持續強勁的管理健康服務需求，特別是殘疾和職業健康評估方面的需求，不斷推動業務績效。
leidos正在利用包括人工智能在內的技術進步，提升服務能力和效率，使公司能夠從未來需求中受益。
通過VA和各種政府和商業項目，在健康與民用領域拓展業務機會。
Risks:
風險：
Given the excellent profitability and complexity managed in their Health & Civil segment, potential competitive pressures could arise with new market entrants in future recompetes.
考慮到在其健康與民用領域取得的卓越盈利能力和管理複雜性，未來市場競爭對手可能會在未來的重新競標中帶來競爭壓力。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
